Log In
Print
BCIQ
Print
Print this Print this
 

Firmagon, Gonax, degarelix (ASP3550)

  Manage Alerts
Collapse Summary General Information
Company Ferring Pharmaceuticals A/S
DescriptionGonadotropin-releasing hormone (GnRH) antagonist
Molecular Target GnRH/LHRH receptor
Mechanism of ActionGnRH/LHRH receptor antagonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentMarketed
Standard IndicationProstate cancer
Indication DetailsTreat advanced hormone-dependent prostate cancer in patients with spinal metastases who are at risk of impending spinal cord compression; Treat hormone-sensitive advanced prostate cancer; Treat prostate cancer
Regulatory Designation

Partner

Astellas Pharma Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today